| Summary: | Objective of the presented study is to introduce telemedicine system that integrates all of the most implemented features that appear in different mobile diabetes applications in addition to blood glucose: tracking of insulin or other medications, communication, diet management, physical activity, weight, blood pressure, personal health record, education, social media, and alerts. Presented telemedicine system employs these features for management of Type 1 and Type 2 diabetes patients. Clinical evaluation after 3 months of intervention showed change of HbA1c in both patient groups was not only statistical significant but it had also a clinical dimension. The HbA1c decreased by 0,5% represents significant change for reduction of diabetic complications. Baseline for HbA1c in 29 T1DM patients: 8.1±1.5% versus 7.5±1.2% (P = 0.008). Baseline for HbA1c in 26 T2DM patients: 7.4±1.2% versus 6.8±1.1% (p=0.001). Results show statistically significant tendency to decrease in T2DM patients in weight 93.2±13.6kg compared to 91.9±14.2kg (P=0.08); and BMI 30.7±4.1 kg/m2 compared to 30.2±4.2 kg/m2 (P=0.08).
|
|---|
